CLINICAL_TRIALS
trial_result
· 2011-09-13
Clinical Trial Update: A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074) [Phase 3]
Summary
Phase 3 study MK0431-074 evaluating adding sitagliptin to background therapy in Type 2 Diabetes Mellitus completed; results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-09-13